Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nanette Wenger

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Global Cardiology Science & Practice|October 4, 2017
Tailoring cardiovascular risk assessment and prevention for women: One size does not fit allNanette Wenger
Nature|October 5, 2017
Perspective: A heartfelt pleaNanette Wenger
Journal of the American College of Cardiology|March 26, 2016
Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?Michael McDaniel, Nanette Wenger
Current Cardiology Reviews|December 6, 2018
Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and OutcomesStacy Westerman, Nanette Wenger
Current Atherosclerosis Reports|June 20, 2020
Menopausal Hormone Therapy: a Comprehensive ReviewGina Lundberg, Pensee Wu, Nanette Wenger
The American Journal of Geriatric Cardiology|January 16, 2004
Uncertainty in medicine: still very much with us in 2004Stephen Scheidt, Nanette Wenger, Michael Weber
The American Journal of Geriatric Cardiology|January 18, 2006
Acute coronary artery disease in the elderly: less ventured, less gainedStephen Scheidt, Nanette Wenger, Michael Weber
The New England Journal of Medicine|July 17, 2004
C-reactive protein and coronary heart diseaseJoAnne M Foody, Antonio M Gotto, Nanette Wenger
Journal of Clinical Lipidology|December 3, 2010
Assessing and addressing risk of cardiovascular disease in perimenopausal and early postmenopausal womenW Virgil Brown, Nanette Wenger, Vera Bittner, et al.
American Heart Journal|June 2, 2007
Sex-specific effects of diabetes on adverse outcomes after percutaneous coronary intervention: trends over timeKimberly P Champney, Emir Veledar, Mitchel Klein, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Global Cardiology Science & Practice|October 4, 2017
Tailoring cardiovascular risk assessment and prevention for women: One size does not fit allNanette Wenger
Nature|October 5, 2017
Perspective: A heartfelt pleaNanette Wenger
Journal of the American College of Cardiology|March 26, 2016
Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?Michael McDaniel, Nanette Wenger
Current Cardiology Reviews|December 6, 2018
Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and OutcomesStacy Westerman, Nanette Wenger
Current Atherosclerosis Reports|June 20, 2020
Menopausal Hormone Therapy: a Comprehensive ReviewGina Lundberg, Pensee Wu, Nanette Wenger
The American Journal of Geriatric Cardiology|January 16, 2004
Uncertainty in medicine: still very much with us in 2004Stephen Scheidt, Nanette Wenger, Michael Weber
The American Journal of Geriatric Cardiology|January 18, 2006
Acute coronary artery disease in the elderly: less ventured, less gainedStephen Scheidt, Nanette Wenger, Michael Weber
The New England Journal of Medicine|July 17, 2004
C-reactive protein and coronary heart diseaseJoAnne M Foody, Antonio M Gotto, Nanette Wenger
Journal of Clinical Lipidology|December 3, 2010
Assessing and addressing risk of cardiovascular disease in perimenopausal and early postmenopausal womenW Virgil Brown, Nanette Wenger, Vera Bittner, et al.
American Heart Journal|June 2, 2007
Sex-specific effects of diabetes on adverse outcomes after percutaneous coronary intervention: trends over timeKimberly P Champney, Emir Veledar, Mitchel Klein, et al.
Pageof 2